| Title |
Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug–drug interactions
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, October 2013
|
| DOI | 10.1007/s00228-013-1597-2 |
| Pubmed ID | |
| Authors |
Emmanuel Eschmann, Patrick E. Beeler, Vladimir Kaplan, Markus Schneemann, Gregor Zünd, Jürg Blaser |
| Abstract |
Hyperkalaemia due to potassium-increasing drug-drug interactions (DDIs) is a clinically important adverse drug event. The purpose of this study was to identify patient- and physician-related risk factors for the development of hyperkalaemia. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 83% |
| Unknown | 1 | 17% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 22 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 5 | 23% |
| Other | 3 | 14% |
| Student > Postgraduate | 3 | 14% |
| Student > Master | 3 | 14% |
| Student > Bachelor | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 7 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 32% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 23% |
| Computer Science | 2 | 9% |
| Nursing and Health Professions | 2 | 9% |
| Unknown | 6 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2013.
All research outputs
#7,322,101
of 23,975,976 outputs
Outputs from European Journal of Clinical Pharmacology
#815
of 2,648 outputs
Outputs of similar age
#65,294
of 216,161 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#7
of 23 outputs
Altmetric has tracked 23,975,976 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,648 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 216,161 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.